MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 25, Issue 22, Pages 2752-2762
Publisher
Baishideng Publishing Group Inc.
Online
2019-06-14
DOI
10.3748/wjg.v25.i22.2752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond
- (2019) Masatoshi Kudo WORLD JOURNAL OF GASTROENTEROLOGY
- The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and Immunotherapies
- (2019) Jens U. Marquardt et al. Targeted Oncology
- MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism
- (2018) Hai‑Feng Zhang et al. Molecular Medicine Reports
- Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
- (2018) Stefania Gorini et al. Oxidative Medicine and Cellular Longevity
- Crosstalk in cancer resistance and metastasis
- (2018) Saeed Norouzi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1
- (2018) Meryem Gülfem Öner et al. GASTROENTEROLOGY
- miR‑34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE‑A/p53 signaling
- (2018) Ge Yang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Structural and functional aspects of P-glycoprotein and its inhibitors
- (2018) Shirin Mollazadeh et al. LIFE SCIENCES
- MiRNA 34a: a therapeutic target for castration-resistant prostate cancer
- (2016) Marine J. Chalanqui et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis
- (2016) Dimiter B. Avtanski et al. Molecular Oncology
- Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review
- (2016) Magdalena KACPERSKA et al. Advances in Clinical and Experimental Medicine
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
- (2014) Mihalis S Kariolis et al. Nature Chemical Biology
- Mir-34a Mimics Are Potential Therapeutic Agents for p53-Mutated and Chemo-Resistant Brain Tumour Cells
- (2014) Yuen Ngan Fan et al. PLoS One
- microRNA-34a Sensitizes Lung Cancer Cell Lines to DDP Treatment Independent of p53 Status
- (2012) Xi Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
- (2012) György Baffy et al. JOURNAL OF HEPATOLOGY
- Effects of quercetin on the bioavailability of doxorubicin in rats: Role of CYP3A4 and P-gp inhibition by quercetin
- (2011) Jun-Shik Choi et al. ARCHIVES OF PHARMACAL RESEARCH
- MiR-34, SIRT1, and p53: The feedback loop
- (2011) Munekazu Yamakuchi et al. CELL CYCLE
- microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)
- (2011) Yang INTERNATIONAL JOURNAL OF ONCOLOGY
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- Hepatocellular Carcinoma: Current Management
- (2009) Charles H. Cha et al. CURRENT PROBLEMS IN SURGERY
- Liver tumor ablation: Percutaneous and open approaches
- (2009) Srikanth Padma et al. JOURNAL OF SURGICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now